1
24
3
| Cat. No. | Product Name | ||
|---|---|---|---|
| CL0067 | Sodium Channel inhibitor kit | ||
| L7400 | 钠通道分子库 | 128 compounds | |
| A unique collection of 128 sodium channel blockers and agonists for high throughput and high content screening; | |||
| L7870 | 可溶性羧酸片段化合物库 | 1807 compounds | |
| L2510 | 脂代谢化合物库 | 496 compounds | |
| A unique collection of 496 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS). | |||
| L7000 | 活性脂质化合物库 | 385 compounds | |
| A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsa | |||
| L2570 | 人代谢物化合物库 | 4532 compounds | |
| A unique collection of 4532 human metabolites for high-throughput, high-content screening. | |||
| L2500 | 人内源代谢化合物库 | 1400 compounds | |
| A unique collection of 1400 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening; | |||
| L2550 | 谷氨酰胺代谢化合物库 | 580 compounds | |
| A unique collection of 580 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and cancer; | |||
| L1720 | 核苷类化合物库 | 337 compounds | |
| A unique collection of 337 nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs; | |||
| L2400 | 内分泌激素分子库 | 813 compounds | |
| A unique collection of 813 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L8710 | 铜死亡化合物库 | 411 compounds | |
| TargetMol’s Cuproptosis Compound Library is a collection of 411 compounds related to copper-dependent death that can be used to study its mechanism and related diseases. | |||
| L2800 | 5-羟色胺分子库 | 275 compounds | |
| A unique collection of 275 compounds targeting serotonin receptors for high throughput screening and high content screening; | |||
| L3510 | 甲基化化合物库 | 131 compounds | |
| 131 methylation-related compounds that can be used for high-throughput and high-content screening. | |||
| L6100 | 天然多酚类化合物库 | 640 compounds | |
| A unique collection of 640 natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L2140 | 癌细胞分化化合物库 | 413 compounds | |
| A unique collection of 413 cancer cell differentiation inducing compounds for high throughput and high content screening; | |||
| L3300 | 组胺&褪黑色素化合物库 | 155 compounds | |
| A unique collection of 155 compounds targeting histaminergic receptor and melatonin receptor for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L1600 | 激酶抑制剂库 | 2230 compounds | |
| A unique collection of 2230 kinase inhibitors for high throughput screening and high content screening for drug discovery in kinase related diseases; | |||
| L1120 | AMPK靶向分子库 | 64 compounds | |
| 64 well-chosen unique AMPK-targeted small molecules； | |||
| L6800 | 中国药典收录天然产物库 | 2070 compounds | |
| A unique collection of 2070 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study; | |||
| L2130 | 抗癌细胞代谢库 | 1280 compounds | |
| A unique collection of 1280 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS); | |||
| L9600 | 多肽分子库 | 533 compounds | |
| 533 peptides can be used in peptide drug development and signaling transduction and mechanism study; | |||
| L1100 | 蛋白酶抑制剂库 | 344 compounds | |
| A unique collection of 344 protease and proteasome inhibitors for research in chemical genomics, and drug screening; | |||
| L7600 | 趋化因子抑制剂库 | 59 compounds | |
| A unique collection of 59 chemokines or chemokine receptors targeted compounds for high throughput and high content screening; | |||
| L8500 | HIF-1化合物库 | 1352 compounds | |
| A unique collection of 1352 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies； | |||
| Cat. No. | Product Name | Form | Specificity Of Inhibition |
|---|---|---|---|
| C0002 |
Phosphatase Inhibitor Cocktail I (100× ddH2O)
磷酸酶抑制剂 Cocktail I |
Solution (100× in ddH2O) | <em><em>Acid</em></em> Phosphatase, Alkaline phosphatase, PTPs, ATPases |
| C0045 |
RIPA Lysis Buffer (Strong)
RIPA Lysis Buffer (Strong) |
||
| C0003 |
Phosphatase Inhibitor Cocktail II (100× DMSO)
磷酸酶抑制剂 Cocktail II |
Solution (100× in DMSO) | Alkaline phosphatases, Ser/Thr phosphatases, <em><em>Acid</em></em> and PP1 and PP2A |
| Cat. No. | Product Name | Target | Signaling Pathways |
|---|---|---|---|
| T12516 | Polyinosinic-polycytidylic acid sodium | Others; TLR; Apoptosis | Immunology/Inflammation; Apoptosis; Others |
| Polyinosinic-polycytidylic acid sodium is a synthetic analog of double-stranded RNA and an agonist of toll-like receptor 3 (TLR3) and retinoic acid inducible gene I (RIG-I)-like receptors (RIG-I and MDA5). | |||
沪公网安备 31010602006700号
